Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bonatek is a dietary supplement marketed by Elcompany and manufactured by Honor in Turkey. It is formulated to support bone health, prevent and treat calcium and vitamin D3 deficiencies, and assist in the management of osteoporosis. The supplement is available in two formulations: a syrup containing calcium, vitamin D3 (cholecalciferol), and vitamin K2 (menaquinone), and sachets containing calcium lactate and vitamin D3. These components work synergistically to enhance calcium absorption, promote bone mineralization, and maintain skeletal integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium + cholecalciferol + menaquinone.